UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Glycolysis-induced drug resistance in tumors—A response to danger signals?

Neoplasia (New York, N.Y.), 2021-02, Vol.23 (2), p.234-245

2021

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-mesenchymal transition: a new target in anticancer drug discovery

Nature reviews. Drug discovery, 2016-05, Vol.15 (5), p.311-325

2016

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities

Blood, 2011-02, Vol.117 (6), p.1792-1798

2011

Link zum Volltext

Verfügbarkeit prüfen

The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?

Cellular and molecular life sciences : CMLS, 2021-02, Vol.78 (3), p.853-865

2021

Link zum Volltext

Verfügbarkeit prüfen

The oxidative stress theory of disease: levels of evidence and epistemological aspects

British journal of pharmacology, 2017-06, Vol.174 (12), p.1784-1796

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor Cell Glycolysis-At the Crossroad of Epithelial-Mesenchymal Transition and Autophagy

Cells (Basel, Switzerland), 2022-03, Vol.11 (6), p.1041

2022

Link zum Volltext

Verfügbarkeit prüfen

On the Role of Glycolysis in Early Tumorigenesis-Permissive and Executioner Effects

Cells (Basel, Switzerland), 2023-04, Vol.12 (8), p.1124

2023

Link zum Volltext

Verfügbarkeit prüfen

The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System

Cells (Basel, Switzerland), 2019-05, Vol.8 (5), p.460

2019

Link zum Volltext

Verfügbarkeit prüfen

How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications

Frontiers in pharmacology, 2018-07, Vol.9, p.714-714

2018

Link zum Volltext

Verfügbarkeit prüfen

Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)-Is There Still Room for Optimism?

Frontiers in oncology, 2019-03, Vol.9, p.167-167

2019

Link zum Volltext

Verfügbarkeit prüfen

Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer

Cells (Basel, Switzerland), 2021-04, Vol.10 (4), p.872

2021

Link zum Volltext

Verfügbarkeit prüfen

Breaching the Blood–Brain Tumor Barrier for Tumor Therapy

Cancers, 2021-05, Vol.13 (10), p.2391

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Oxidative Metabolism in Tumorigenesis and Drug Resistance

Discovery medicine, 2024-06, Vol.36 (185), p.1109

2024

Link zum Volltext

Verfügbarkeit prüfen

How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugs

Advanced drug delivery reviews, 2012-01, Vol.64 (1), p.53-68

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

Blood, 2003-08, Vol.102 (3), p.996-999

2003

Link zum Volltext

Verfügbarkeit prüfen

Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness

Biochimica et biophysica acta. Reviews on cancer, 2017-12, Vol.1868 (2), p.571-583

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells

Molecular cancer, 2017-01, Vol.16 (1), p.3-3, Article 3

2017

Link zum Volltext

Verfügbarkeit prüfen

Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers

Pflügers Archiv, 2018, Vol.470 (1), p.199-210

2018

Link zum Volltext

Verfügbarkeit prüfen

The N-Terminal Fragment of Chromogranin A, Vasostatin-1 Protects Mice From Acute or Chronic Colitis Upon Oral Administration

Digestive diseases and sciences, 2012-05, Vol.57 (5), p.1227-1237

2012

Link zum Volltext

Verfügbarkeit prüfen

Improving drug penetration to curb tumor drug resistance

Drug discovery today, 2012-10, Vol.17 (19-20), p.1139-1146

2012

Link zum Volltext

Verfügbarkeit prüfen

From "high" ZEB1 to "low" B-cell lymphoma 2-interacting mediator of cell death (BIM)-an epithelial-mesenchymal transition (EMT)-associated drug resistance pathway elucidated

Journal of thoracic disease, 2019-01, Vol.11 (1), p.1-5

2019

Link zum Volltext

Verfügbarkeit prüfen

Context-Dependent Pharmacological Effects of Metformin on the Immune System

Trends in pharmacological sciences (Regular ed.), 2020-03, Vol.41 (3), p.162-171

2020

Link zum Volltext

Verfügbarkeit prüfen

Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads

International journal of cancer, 2014-09, Vol.135 (6), p.1265-1276

2014

Link zum Volltext

Verfügbarkeit prüfen

Ways to improve tumor uptake and penetration of drugs into solid tumors

2014

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Glucose Uptake Protects Liver from Lipopolysaccharide and d -Galactosamine, Acetaminophen, and Alpha-Amanitin in Mice

The American journal of pathology, 2009-09, Vol.175 (3), p.1066-1076

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Glycolysis-induced drug resistance in tumors—A response to danger signals?

Epithelial-mesenchymal transition: a new target in anticancer drug discovery

Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities

The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?

The oxidative stress theory of disease: levels of evidence and epistemological aspects

Tumor Cell Glycolysis-At the Crossroad of Epithelial-Mesenchymal Transition and Autophagy

On the Role of Glycolysis in Early Tumorigenesis-Permissive and Executioner Effects

The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System

How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications

Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)-Is There Still Room for Optimism?

Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer

Breaching the Blood–Brain Tumor Barrier for Tumor Therapy

The Role of Oxidative Metabolism in Tumorigenesis and Drug Resistance

How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugs

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness

The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells

Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers

The N-Terminal Fragment of Chromogranin A, Vasostatin-1 Protects Mice From Acute or Chronic Colitis Upon Oral Administration

Improving drug penetration to curb tumor drug resistance

From "high" ZEB1 to "low" B-cell lymphoma 2-interacting mediator of cell death (BIM)-an epithelial-mesenchymal transition (EMT)-associated drug resistance pathway elucidated

Context-Dependent Pharmacological Effects of Metformin on the Immune System

Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads

Ways to improve tumor uptake and penetration of drugs into solid tumors

Intestinal Glucose Uptake Protects Liver from Lipopolysaccharide and d -Galactosamine, Acetaminophen, and Alpha-Amanitin in Mice

Suchergebnisse filtern